Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Gross Margin (2016 - 2025)

Veracyte (VCYT) has disclosed Gross Margin for 14 consecutive years, with 72.51% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 612.0% to 72.51% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 70.1% through Dec 2025, up 322.0% year-over-year, with the annual reading at 70.1% for FY2025, 322.0% up from the prior year.
  • Gross Margin hit 72.51% in Q4 2025 for Veracyte, up from 69.22% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 72.51% in Q4 2025 to a low of 55.6% in Q1 2021.
  • Historically, Gross Margin has averaged 66.32% across 5 years, with a median of 66.7% in 2021.
  • Biggest five-year swings in Gross Margin: soared 1600bps in 2021 and later tumbled -526bps in 2023.
  • Year by year, Gross Margin stood at 67.01% in 2021, then rose by 4bps to 69.95% in 2022, then fell by -6bps to 65.98% in 2023, then grew by 1bps to 66.39% in 2024, then grew by 9bps to 72.51% in 2025.
  • Business Quant data shows Gross Margin for VCYT at 72.51% in Q4 2025, 69.22% in Q3 2025, and 68.97% in Q2 2025.